S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.42 (+0.28%)
AAPL   174.02 (-0.30%)
MSFT   290.01 (-0.45%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.22 (+0.08%)
TSLA   908.10 (-0.43%)
NVDA   187.50 (+2.26%)
NIO   19.90 (-0.90%)
BABA   90.71 (+1.05%)
AMD   100.59 (+2.36%)
MU   63.03 (+2.29%)
T   18.43 (+0.05%)
CGC   3.80 (-6.40%)
F   16.15 (+0.75%)
GE   79.23 (-0.86%)
DIS   122.70 (-0.09%)
AMC   19.49 (-8.75%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.81 (+1.52%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.42 (+0.28%)
AAPL   174.02 (-0.30%)
MSFT   290.01 (-0.45%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.22 (+0.08%)
TSLA   908.10 (-0.43%)
NVDA   187.50 (+2.26%)
NIO   19.90 (-0.90%)
BABA   90.71 (+1.05%)
AMD   100.59 (+2.36%)
MU   63.03 (+2.29%)
T   18.43 (+0.05%)
CGC   3.80 (-6.40%)
F   16.15 (+0.75%)
GE   79.23 (-0.86%)
DIS   122.70 (-0.09%)
AMC   19.49 (-8.75%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.81 (+1.52%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.42 (+0.28%)
AAPL   174.02 (-0.30%)
MSFT   290.01 (-0.45%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.22 (+0.08%)
TSLA   908.10 (-0.43%)
NVDA   187.50 (+2.26%)
NIO   19.90 (-0.90%)
BABA   90.71 (+1.05%)
AMD   100.59 (+2.36%)
MU   63.03 (+2.29%)
T   18.43 (+0.05%)
CGC   3.80 (-6.40%)
F   16.15 (+0.75%)
GE   79.23 (-0.86%)
DIS   122.70 (-0.09%)
AMC   19.49 (-8.75%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.81 (+1.52%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.42 (+0.28%)
AAPL   174.02 (-0.30%)
MSFT   290.01 (-0.45%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.22 (+0.08%)
TSLA   908.10 (-0.43%)
NVDA   187.50 (+2.26%)
NIO   19.90 (-0.90%)
BABA   90.71 (+1.05%)
AMD   100.59 (+2.36%)
MU   63.03 (+2.29%)
T   18.43 (+0.05%)
CGC   3.80 (-6.40%)
F   16.15 (+0.75%)
GE   79.23 (-0.86%)
DIS   122.70 (-0.09%)
AMC   19.49 (-8.75%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.81 (+1.52%)
NASDAQ:MOTS

Motus GI - MOTS Stock Forecast, Price & News

$3.90
-0.07 (-1.76%)
(As of 08/18/2022 03:05 PM ET)
Add
Compare
Today's Range
$3.82
$3.91
50-Day Range
$3.66
$6.00
52-Week Range
$3.60
$16.45
Volume
3,078 shs
Average Volume
374,779 shs
Market Capitalization
$10.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.50

Motus GI MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
195.6% Upside
$11.50 Price Target
Short Interest
Bearish
5.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.07mentions of Motus GI in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($8.40) to ($5.84) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

Medical Sector

957th out of 1,122 stocks

Surgical & Medical Instruments Industry

92nd out of 112 stocks

MOTS stock logo

About Motus GI (NASDAQ:MOTS) Stock

Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Wall Street Analyst Weigh In

MOTS has been the topic of several research analyst reports. HC Wainwright decreased their price target on Motus GI from $20.00 to $11.00 and set a "buy" rating on the stock in a research note on Monday. Alliance Global Partners decreased their price target on Motus GI from $24.00 to $12.00 in a research note on Thursday, August 11th.

Motus GI Price Performance

Shares of NASDAQ:MOTS opened at $3.97 on Thursday. The business's 50 day simple moving average is $4.92 and its 200-day simple moving average is $5.96. The firm has a market capitalization of $10.93 million, a price-to-earnings ratio of -0.52 and a beta of 1.96. The company has a debt-to-equity ratio of 2.46, a current ratio of 4.28 and a quick ratio of 4.03. Motus GI has a 12 month low of $3.60 and a 12 month high of $16.45.

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

MOTS Stock News Headlines

Recap: Motus GI Q2 Earnings
Motus GI (MOTS) Scheduled to Post Earnings on Thursday
Motus GI Announces 1-FOR-20 Reverse Stock Split
See More Headlines
Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

MOTS Company Calendar

Last Earnings
11/12/2021
Today
8/18/2022
Next Earnings (Estimated)
11/11/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MOTS
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.50
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+194.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-19,030,000.00
Net Margins
-4,402.92%
Pretax Margin
-4,402.92%

Debt

Sales & Book Value

Annual Sales
$390,000.00
Book Value
$1.44 per share

Miscellaneous

Free Float
2,511,000
Market Cap
$10.73 million
Optionable
Not Optionable
Beta
1.96














MOTS Stock - Frequently Asked Questions

Should I buy or sell Motus GI stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MOTS shares.
View MOTS analyst ratings
or view top-rated stocks.

What is Motus GI's stock price forecast for 2022?

2 analysts have issued 12 month target prices for Motus GI's stock. Their MOTS share price forecasts range from $11.00 to $12.00. On average, they anticipate the company's stock price to reach $11.50 in the next twelve months. This suggests a possible upside of 189.7% from the stock's current price.
View analysts price targets for MOTS
or view top-rated stocks among Wall Street analysts.

How have MOTS shares performed in 2022?

Motus GI's stock was trading at $9.34 at the beginning of the year. Since then, MOTS shares have decreased by 57.5% and is now trading at $3.97.
View the best growth stocks for 2022 here
.

When is Motus GI's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 11th 2022.
View our MOTS earnings forecast
.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its quarterly earnings results on Friday, November, 12th. The company reported ($2.00) earnings per share for the quarter, hitting analysts' consensus estimates of ($2.00). The company earned $0.14 million during the quarter, compared to analyst estimates of $0.12 million. Motus GI had a negative net margin of 4,402.92% and a negative trailing twelve-month return on equity of 214.97%. During the same quarter in the prior year, the firm earned ($2.60) EPS.

When did Motus GI's stock split?

Motus GI's stock reverse split on Tuesday, July 26th 2022. The 1-20 reverse split was announced on Tuesday, July 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Motus GI own?
When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Who are Motus GI's major shareholders?

Motus GI's stock is owned by a variety of retail and institutional investors. Top institutional investors include Virtu Financial LLC (7.28%), Renaissance Technologies LLC (4.63%) and Millennium Management LLC (4.18%). Insiders that own company stock include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Gary E Jacobs, Larry N Feinberg, Mark Pomeranz, Perceptive Advisors Llc and Timothy P Moran.
View institutional ownership trends
.

How do I buy shares of Motus GI?

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $3.97.

How much money does Motus GI make?

Motus GI (NASDAQ:MOTS) has a market capitalization of $10.92 million and generates $390,000.00 in revenue each year. The company earns $-19,030,000.00 in net income (profit) each year or ($7.66) on an earnings per share basis.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The official website for the company is www.motusgi.com. The company can be reached via phone at (954) 541-8000, via email at ir@motusgi.com, or via fax at 954-541-8265.

This page (NASDAQ:MOTS) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.